# GEA Group

the industrial forced-circulation, draft-tube-baffled and Oslo growth-type workhorses for steroid, vitamin and antibiotic APIs.

Source: https://en.bioecon.ru/companies/gea-group/
Updated: 2026-08-15

- Country: Germany
- Ticker: XETR:G1A

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | EUR 5.495 billion (fiscal year 2025) | https://cdn.gea.com/-/media/investors/annual-report/2025/factsheet-2026-en.pdf?rev=4ee575f9cb53418c82a5731bce878974, https://www.gea.com/-/media/company/gea-group-company-presentation-en.pdf |
| Headcount | 18,628 employees (as of December 31, 2025) | https://cdn.gea.com/-/media/investors/annual-report/2025/factsheet-2026-en.pdf?rev=4ee575f9cb53418c82a5731bce878974, https://www.gea.com/-/media/company/gea-group-company-presentation-en.pdf |
| Production site | Centers of excellence for crystallization located in France, the Netherlands, and Germany; technology/manufacturing sites include Elsdorf (Germany), Koszalin (Poland), Parma (Italy), and Suzhou (China) | https://www.chemengonline.com/partner-content/gea-crystallization-and-testing-capabilities-because-every-crystallization-plant-begins-in-the-laboratory/, https://www.gea.com/en/assets/250175/ |
| Certification | ISO 9001, ASME BPE, 3-A Sanitary Standard, EHEDG certification (for specific components/systems) | https://cdn.gea.com/-/media/migratedfromtridion/stories/vaccine-production-66825.pdf?rev=2f54b62a1d32422eb6923dff67e77329, https://www.gea.com/assets/159077/, https://www.gea.com/assets/171153/ |
| Regulatory approval | Compliant with cGMP, FDA, EMA, PED, GAMP, and 21 CFR Part 11 guidelines | https://cdn.gea.com/-/media/migratedfromtridion/stories/vaccine-production-66825.pdf?rev=2f54b62a1d32422eb6923dff67e77329, https://dataintelo.com/report/erythritol-production-equipment-market, https://www.gea.com/assets/171153/ |
| Capacity | Industrial plants installed with dewatering capacities ranging from 200 to 200,000 tons per year | https://www.gea.com/en/assets/250175/ |
| Funding | Publicly traded on the German MDAX/DAX; not applicable for standard VC-style funding rounds | https://cdn.gea.com/-/media/investors/annual-report/2025/factsheet-2026-en.pdf?rev=4ee575f9cb53418c82a5731bce878974, https://cdn.gea.com/-/media/investors/annual-report/2025/press-release-annual-report-2025-en.pdf?rev=c5073b5473654676b0aa71c8b5c9f3ed, https://cdn.gea.com/-/media/investors/annual-report/2025/roadshow-presentation-annual-report-2025-en-only.pdf?rev=d905ca47bb9743059757ce06fa553818 |

Independent sources: cdn.gea.com, chemengonline.com, dataintelo.com, gea.com

## Technologies

- [Crystallization equipment for pharmaceutical APIs](https://en.bioecon.ru/technology/crystallization-equipment-pharma-api/)
- [Disc-stack centrifuges](https://en.bioecon.ru/technology/disc-stack-centrifuges/)
- [Fermentation-capacity brokerage](https://en.bioecon.ru/technology/fermentation-capacity-brokerage/)
- [Gas fermentation reactors](https://en.bioecon.ru/technology/gas-fermentation-reactors/)
- [Lyophilizers and freeze dryers](https://en.bioecon.ru/technology/lyophilizers-freeze-dryers/)
- [Oil and fat industry biotech](https://en.bioecon.ru/technology/oil-fat-industry-biotech/)